Of interest, several other known genes coding for satiety-related receptors are highly enriched in the nodose, including the glucagon-like peptide 1 receptor (Glp1r), which also suppresses appetite and has been targeted using synthetic analogs for type II diabetes and weight loss (Vilsboll et al., 2012). Here, GLP1R is linked to type 2 diabetes mellitus.